Dual-energy subtraction chest radiography improves lung cancer detection

Dual-energy subtraction chest radiography has the potential to improve radiologists' performance for the detection of small missed lung cancers, according to a study published in the April issue of the American Journal of Roentology.

Feng Li and colleagues, from the department of radiology at the University of Chicago, selected 19 patients with previously missed nodular cancers, in which the radiology report did not mention a nodule that was visible in retrospect.

Dual-energy subtraction radiographs of 19 patients with cancer and 16 patients without cancer were used for an observer study, the authors wrote. Also, the researchers said that six radiologists indicated their confidence level regarding the presence of a lung cancer and, if they thought a cancer was present, marked the most likely position for each lung, first using standard posteroanterior and lateral chest radiographs and then using both soft-tissue and bone dual-energy subtraction images along with standard radiographs.

The researchers also analyzed the indicated locations of cancers and false-positives.

The investigators reported that the average area under the ROC curve value for the six radiologists was improved from 0.718 to 0.816, a statistically significant amount, and the average sensitivity (correct localizations) for 19 previously missed cancers was also significantly improved from 40 percent to 59 percent with the aid of dual-energy subtraction images.

Li and colleagues found that the average number of false-positive localizations on 70 lungs was 10 without and nine with dual-energy subtraction images.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.